FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to hematology, cardiology, endocrinology, and can be used for optimisation of functional reactivity of cardiovascular system (CVS) in patients with arterial hypertension with metabolic syndrome and heart failure of I-IIA stage. For this purpose, first, state of CVS functional reactivity at physicoemotional load is estimated. Systolic, diastolic, average dynamic (APavdyn.), heart rate (HR) are registered. On the basis of obtained...

FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, namely to haematology, cardiology and endocrinology, and can be used for correction of the blood microvesicle level in the patients with abdominal obesity and impaired glucose tolerance. That is ensured by the administration of Pioglitazone 30 mg once in the morning with underlying individual low-calorie diet and graduated physical activity for at least 9 weeks. ^ EFFECT: method ensures reduced risk of thrombotic complications, higher c...

FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, namely to haematology, cardiology and endocrinology, and concerns normalisation of the blood microvesicle level in arterial hypertension, abdominal obesity and type II diabetes mellitus. That is ensured by the specific low-calorie diet combined with graduated physical activity. In addition, Valsartan 80 mg once in the morning and Pioglitazone 30 mg once in the morning are prescribed. The length of treatment is at least 6 weeks. ^ EFFECT...

FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, particularly to haematology, cardiology, endocrinology and can be used for optimising the functional responsiveness of cardiovascular system (CVS) in elderly and senile arterial hypertension and type II diabetes mellitus. That is ensured by estimating the state of functional responsiveness of the CVS in psychoemotional load. And systolic, diastolic, average dynamic pressure and heart rate (HR) are recorded. These data are used to evalua...

FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to hematology, cardiology, endocrinology, and can be used for optimisation of cardiovascular system (CVS) functional reactivity in patients with arterial hypertension and type II diabetes mellitus. For this purpose, first evaluation of state of CVS functional reactivity under psychoemotional load is carried out. Systolic, diastolic, mean dynamic (APm.dyn.) pressure, heart rate (HR) are registered. On the basis of said parametres...

FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to hematology, cardiology, endocrinology, and can be applied for normalisation of microvesicle level in blood in case of glucose tolerance disturbance. For this purpose introduced is pioglitazone 30 mg 1 time in the morning and dosed physical loadings are prescribed. Duration of treatment is not less than 6 weeks. ^ EFFECT: method results in normalisation of microvesicle level in blood of patients of said category, reducingmanif...

FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, namely to haematology, cardiology, endocrinology, and can be used for decreasing the blood microvesicle concentration in the patients with arterial hypertension and impaired glucose tolerance. That is ensured by administration of Valsartan 80 mg once in the morning, Pioglitazone 30 mg once in the morning and prescribed graduated physical activity. ^ EFFECT: invention provides normalisation of the blood microvesicle level in the case pat...

FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, particularly to cardiology, and concerns normalising the functional responsiveness of cardiovascular system in elderly and senile patients suffering arterial hypertension and metabolic syndrom. That is ensured by estimating the condition of functional reactivity of the CVS in psychoemotional load by recording systolic, diastolic, average dynamic pressure (BPav.dyn.) and heart rate (HR). These data are used to evaluate a functional respo...

FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to cardiology, and relates normalisation of cardio-vascular system functional reactivity in case of arterial hypertension with metabolic syndrome. For this purpose evaluation of CVS functional reactivity state under psychoemotional load is performed by registration of systolic diastolic, mean dynamic pressure and heart beat rate (HBR). On the basis of said data functional reactivity index (FRI) is determined before and after the...

FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, namely cardiology, and concerns normalising functional reactivity of cardiovascular system (CVS) in arterial hypertension and impaired glucose tolerance. That is ensured by estimating the condition of functional reactivity of the CVS in psychoemotional load by recording systolic, diastolic, average dynamic pressure (BPav.dyn.) and heart rate (HR). These data are used to evaluate a functional responsiveness index (FRI) before and after s...